Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download outback trial
Document related concepts
no text concepts found
Transcript
OUTBACK TRIAL Trial Title A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone. Trial Acronym OUTBACK Trial Protocol Number ANZGOG 0902 Key Question Does the addition of adjuvant chemotherapy to standard cisplatin-based chemoradiation improve overall survival in women with locally advanced cervical cancer? Trial Design A Randomised controlled multi-centre clinical trial ANZ Study Chairs Dr Linda Mileshkin ANZ Coordinating Centre NHMRC Clinical Trials Centre – University of Sydney Trial Coordinator Ilka Kolodziej Trial [email protected] Tumour Stream Locally advanced cervical cancer Intervention Participants will be randomised to two groups. Both groups will be treated with standard external beam radiation treatment to the pelvis and brachytherapy (internal radiotherapy). Both groups will receive cisplatin intravenously during the radiation therapy. One group will also receive 4 cycles of 3 weekly adjuvant chemotherapy with carboplatin and paclitaxel after completion of chemoradiation. Collaborating Partner Eligibility Patients with locally advanced cervical cancer which is suitable for primary treatment with chemoradiation. Status Open to recruitment Participating Sites Click through to ANZGOG website here Australia New Zealand Gynaecological Oncology Group 92-94 Parramatta Road, CAMPERDOWN NSW 2050 Phone: 61 2 8071 4880 Fax: 61 2 8071 4888 [email protected] www.anzgog.org.au ABN: 69 138 649 028 ACN: 138 649 028
